David Hadley joined TVC in 2015. For TVC, he is responsible for evaluating IP, marketing, and commercializing technologies with a portfolio focus on medical devices, therapeutics, drug delivery, diagnostics, and clinical software. He brings broad experience from both industry and academia and nearly ten years’ experience in technology commercialization. During that time and has successfully worked with inventors and commercial partners to advance technologies to the market through funding opportunities, establishing collaborations, start-ups, and negotiating licenses.
David has worked in various roles in small, medium and large sized biotech and pharmaceutical companies. He began his bioinformatics career at Incyte Pharmaceuticals and continued on building large genome analysis pipelines at Aventis and Syngenta. He gained valuable regulatory while working on the diabetes therapies Symlin® and Byetta® at Amylin Pharmaceuticals. Most recently, David was doing protein-based biomarker and diagnostics business development at SomaLogic in Colorado.
|Title: Technology Manager|
615 Arapeen Drive
Salt Lake City, UT 84108